by Michael Morgenstern, MD | Jun 28, 2022 | Blog, Sleep disorders
If you can’t fall asleep or stay asleep you are not alone. Most people experience brief periods of “Insomnia.” It can interfere with your ability to function during the day, reduce your energy level and affect your quality of life. Insomnia may be...
by Michael Morgenstern, MD | Jun 14, 2022 | Blog, Sleep disorders
New technology allowing users to view sleep data have recently become widely available. One of these monitors called Fitbit utilize motion detectors using similar technology to the Nintendo Wii. It allows users to view how many steps they have taken during the day....
by Michael Morgenstern, MD | May 20, 2022 | Blog, Sleep disorders
Sleep experts agree that Cognitive Behavioral Therapy for Insomnia (CBT-I) is the most effective therapy for Chronic Insomnia. Evidence shows that CBT-I offers better, longer lasting results than medications, without harmful side effects. CBT-I is usually provided by...
by Michael Morgenstern, MD | Feb 10, 2022 | Blog, Condition, headache, stroke
Bob Saget suffered a brain bleed that ultimately caused his death, according to his family. The 57-year-old comedian and actor was found in his hotel room, he wasn’t breathing and had no pulse. Paramedics showed up but couldn’t resuscitate him, and he was pronounced...
by Michael Morgenstern, MD | Feb 2, 2022 | Blog, migraine, pain
Headaches are painful, debilitating, and sometimes even life-threatening. If you suffer from chronic headaches or migraines, you’re not alone—about 15% of Americans do, according to the Migraine Research Foundation (MRF). Unfortunately, just under half of all migraine...
by Michael Morgenstern, MD | Sep 18, 2018 | Blog, Health care, medical marijuana
On June 25th, 2018, the U.S. Food & Drug Administration (FDA) approved Epidiolex (cannabidiol, CBD) for treatment of seizures associated with Lennox-Gastaut Syndrome and Dravet Syndrome, two forms of epilepsy. Epidiolex is the first plant-based drug derived from...
Recent Comments